Chlamydia is the most common notifiable disease in the U.S. with nearly 1.5 million cases reported to the CDC in 2015. Chlamydia infection rates are especially high among sexually active women 24 years and younger. Chlamydial infections in women are usually asymptomatic. Untreated infection can result in pelvic inflammatory disease (PID), which is a major cause of infertility, ectopic pregnancy, and chronic pelvic pain.
CDC recommends annual chlamydia screening for all women “younger than 25 years, as well as older women with risk factors such as new or multiple sex partners, or a sex partner who has a sexually transmitted infection.” Despite this recommendation, routine screening is infrequent -- less than half of at-risk women under 25 years old who are enrolled in health plans get tested for chlamydia.
Using the Performance Measure for Quality Improvement
- Chlamydia Screening Performance Measure Calculator: An easy tool to help calculate the chlamydia measure using Family Planning Annual Report (FPAR) data.
- Chlamydia Screening Performance Measure Specifications: Inclusion and exclusion criteria and data collection methods developed by National Committee for Quality Assurance.
- Family Planning Performance Dashboard: An interactive way for Title X grantees to compare themselves to others on the chlamydia and contraceptive care performance measures. Grantees and service sites can also track performance on these measures on a graph over time.
Resources to Increase Screening Rates
- Why Screen for Chlamydia?: An implementation guide for healthcare providers to improve delivery of screening and treatment for chlamydia.
- GYT: Get Yourself Tested Campaign: Free campaign materials from the CDC to raise awareness of the importance of STD screening.
- STD Billing and Reimbursement Toolkit: A toolkit to overcome challenges related to billing, coding, and reimbursement for STD screening and treatment.